Treatment regimens for multiple myeloma have expanded significantly over the last decade and have improved outcomes in patients. This expansion has created knowledge and practice gaps among community oncology providers in administration protocol and adverse event (AE) management.
The goal of this project was to assess practice patterns, monitoring and management of treatment-related AEs, supportive care services, and barriers to treatment for patients with multiple myeloma.
For more information on this study contact Mary Stanley, LMSW, PMP at mstanley@accc-cancer.org.
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.

In a recent conversation with ACCC, Kevan Simms, MBA, PMP, Assistant Vice President of Precision Medicine at Ochsner Health, shared how his organization is building a scalable stewardship model that not only improves current oncology care but also prepares for the future.

In a recent conversation with ACCC, DiMe Associate Program Director Ian Miller discussed what responsible AI adoption looks like in practice, particularly for organizations early in their AI journey and seeking clearer guidance on how to evaluate, prioritize, and implement these tools.

In the recent NCCN policy summit "Health Literacy in the Cancer Care Digital Age," speakers and panelists discussed how best to communicate with patients and foster the responsible use of emerging technologies, with a strong focus on shared decision-making.

In her recent appearance on Sanofi’s Patient Advocacy Voices podcast, ACCC Executive Director Meagan O’Neill discusses the operational gaps that delay access to cancer care, structural barriers that impact patient outcomes, and ACCC’s mission to supply a “how to” approach in bringing breakthrough science to cancer programs in the form of practical solutions.
